China's Transgenic Cancer Fighting Cow

The cow, which can produce CD20 antibodies in its milk, was born in Beijing on Aug. 2 and a dozen more are due to be born next month.

Researchers said mass breeding of the animal would enable China to mass produce the therapeutic proteins cheaply.

The human monoclonal (produced from a single cell) antibodies could be purified from the milk of the transgenic cow, and used to treat B cell lymphomas and leukemias and some auto-immune diseases, said research team leader Li Ning, an academician with China Academy of Engineering.

"After 10 days of careful observation, we are happy to see the cow is very healthy," said Li, whose laboratory is based in the China Agriculture University.

TheCattleSite News Desk

Sign up for our
regular news updates

Latest Dairy Industry News

•   FMD NEWS: More Chinese Cattle Hit By FMD
•   Preventing Spoilage In Cheese
•   Rift Valley Fever Threatens Botswana
•   FDA Seeks Order Against Michigan Dairy
•   Competing To Be The Top Dairy Farmer
•   Wet, Muddy Conditions Can Lead To Lameness
•   Weekly Roberts Report
•   Study: Agri-Food Industry’s View on Animal Cloning
•   Lameness In Ruminants Addressed In NZ
•   No Bull - The Importance Of Free TB Testing
•   Standard For Sustainable Cattle Production Systems
•   Make Good Breeding Decisions This Autumn
•   Cattle Producers Rally Against GIPSA Rule
•   Lowering The Cost Of Hot Water On Dairy Farms
•   International Workshop On Dairy Science